COO
Cooper Companies, Inc. Health Care Ophthalmic Goods S&P 500Russell 3000
$59.55Close
$11.7BMarket cap
$53.27 – $84.3252-week range
Dec 3, 2026Next report
Highlights
Strengths
- Tight base near its pivot pullbacks 35% → 7%; 3.2% above its $57.69 pivot
- Earnings growing EPS +355% year on year, faster than the quarter before (+547 pts)
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 17 · weaker than 83% of stocks over 12 months
- Far from its high 29% below its 52-week high
- Distribution down-day volume 1.6× up-day volume over 50 sessions
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
29%
1wk
down 2.7%
price change
1mo
up 5.3%
price change
12-month return
down 15%
market up 11% ·
its own down 25%
F-score
5 / 9
Mixed
Altman Z
3.16
Low risk
P/E
31.1×
price / earnings
PEG
—
P/E / EPS growth
P/B
1.4×
price / book
Earnings yield
up 4.9%
EBIT / enterprise value
Cheaper than
68%
of the market · cheap
Revenue growth
up 5%
year on year
EPS growth
up 355%
latest quarter · +547 pts
Sales growth
up 1%
latest quarter · -7 pts
ROE
up 5%
return on equity
Free cash margin
up 11%
$433.7M FCF
D/E
0.30
long-term debt / equity
Net debt / EBITDA
2.2×
Interest cover
—EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- gross margin narrowed
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- no new shares issued
Trade setup
ATR%
2.7%
$1.61 a day · 2×ATR $56.34
RS
17 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
2.1×
vs 50-day average
Up/down volume
0.63
50 sessions
Implied move
13.1%
by Dec 18, 2026 · report Dec 3, 2026
Contractions
2
35% → 7%
Pivot
$57.69
3.2% above
Volume dry-up
0.8×
10 vs 50 sessions
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Gross margin narrowing Gross margin fell from 66.6% to 65.5%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported
Sep 9, 2026
Last shock
Sep 10, 2026-15% in one session7.6× volumeon results+10% since
Options
$6,71636.6% IV · activity
Financials
- Gross 66%
- Net 9%
- Free cash 11%
- Cash
- Long-term debt
| FY2020Oct 31, 2020 | FY2021Oct 31, 2021 | FY2022Oct 31, 2022 | FY2023Oct 31, 2023 | FY2024Oct 31, 2024 | FY2025Oct 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B |
| Gross margin | 63% | 67% | 65% | 66% | 67% | 66% |
| Operating income | $311.8M | $505.8M | $507.6M | $533.1M | $705.7M | $682.9M |
| Net income | $238.4M | $2.9B | $385.8M | $294.2M | $392.3M | $374.9M |
| Net margin | 10% | 101% | 12% | 8% | 10% | 9% |
| Earnings per share | $1.20 | $14.78 | $1.94 | $1.48 | $1.96 | $1.87 |
| Free cash flow | $176.2M | $524.2M | $450.4M | $215.0M | $288.1M | $433.7M |
| Free cash margin | 7% | 18% | 14% | 6% | 7% | 11% |
| Cash | $115.9M | $95.9M | $138.2M | $120.8M | $107.6M | $110.6M |
| Long-term debt | $1.4B | $1.4B | $2.3B | $2.5B | $2.5B | $2.5B |
| Shareholders' equity | $3.8B | $6.9B | $7.2B | $7.6B | $8.1B | $8.2B |
| Shares outstanding | 196.40m | 197.20m | 197.20m | 198.10m | 199.60m | 195.90m |
Next report
Dec 3, 2026
Expected move The move, either way, the option market prices in through the next scheduled report: the at-the-money straddle for the first expiry that contains it, over the price. It includes the days around the report, so it slightly overstates the report alone. Methodology
±13.1%
$52 – $67 by Dec 18, 2026
Usual move The median, over the company's last four reports, of how far the stock moved either way from the close before the filing to the close of the session after it. Methodology
±9.4%
last 4: -20.0% · +11.6% · -6.6% · +7.1%
Expected against usual The move the options price through this report over the move the last four reports delivered. Above 1 the event is priced bigger than the company's own record; below 1, smaller. A price, not a forecast: it says what protection through the report costs, not which way the stock will go. Methodology
Bigger than usual
1.4× the usual move
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $56 – $62 ±5.1% by Nov 20, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Bigger 36.6% priced · 30.6% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- Calmer
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs less
Positioning
- Premium traded
- $6,716 calls $3,801 · puts $2,915 · latest session
- 0.77× +0.18 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +4.15k · puts +3.06k past week
For options traders: ATM IV 36.6% (+0.2% 1w) · 1m ÷ 3m IV 0.59 · 25Δ skew 4.4 pts · Net GEX $960,357
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Sep 9, 2026 | Quarterly ↗ | Jul 31, 2026 | 40d |
| Jun 5, 2026 | Quarterly ↗ | Apr 30, 2026 | 36d |
| Mar 6, 2026 | Quarterly ↗ | Jan 31, 2026 | 34d |
| Dec 5, 2025 | Annual ↗ | Oct 31, 2025 | 35d |
| Aug 28, 2025 | Quarterly ↗ | Jul 31, 2025 | 28d |
| May 30, 2025 | Quarterly ↗ | Apr 30, 2025 | 30d |
| Mar 7, 2025 | Quarterly ↗ | Jan 31, 2025 | 35d |
| Dec 6, 2024 | Annual ↗ | Oct 31, 2024 | 36d |
| Aug 29, 2024 | Quarterly ↗ | Jul 31, 2024 | 29d |
| May 31, 2024 | Quarterly ↗ | Apr 30, 2024 | 31d |
| Mar 1, 2024 | Quarterly ↗ | Jan 31, 2024 | 30d |
| Dec 8, 2023 | Annual ↗ | Oct 31, 2023 | 38d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 27, 2026 | Director or officer change · Regulation FD ↗ |
| Sep 9, 2026 | Results · Other events ↗ |
| Jun 4, 2026 | Results · Other events ↗ |
| May 4, 2026 | Director or officer change ↗ |
| Apr 8, 2026 | Shareholder vote ↗ |
| Mar 5, 2026 | Results ↗ |
| Feb 4, 2026 | Material agreement ↗ |
| Dec 23, 2025 | Material agreement · Director or officer change · Regulation FD ↗ |
| Dec 12, 2025 | Director or officer change ↗ |
| Dec 4, 2025 | Results · Director or officer change · Regulation FD ↗ |
| Aug 27, 2025 | Results ↗ |
| May 29, 2025 | Results ↗ |